Products & Services
Company Description
Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.
Business Contact Information
- Phone
- (949) 238-8090
- Fax
- No data
- Website
- http://www.tokaipharma.com
- No data
- No data
- Address
- 19900 MacArthur Blvd, Irvine, California, 92612-2443, United States
Industry & Classification
- Industry Name Level 1
- No data
- Industry Name Level 2
- No data
- Industry Name Level 3
- No data
NAICS Codes
No data
SIC Codes
No data
Company Details
- Employees
- No data
- Annual Revenue
- No data
- Established
- No data
- Total Funding
- No data
- Latest Funding
- No data
Related Companies
Own this business?
Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.
Prefer email? privacy@facturmfg.com